Skip to main content
editorial
. 2023 Mar 31;12(2):252–255. doi: 10.21037/hbsn-23-97

Figure 1.

Figure 1

Outline of hepatocellular carcinoma treatment modalities based on the stage of tumor and liver disease and potential use of ICI, TKI, VEGF agents. BCLC, Barcelona Clinic Liver Cancer; ICIs, immune checkpoint inhibitors; anti-VEGF, anti-vascular endothelial growth factor; TKIs, tyrosine kinase inhibitors.